Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PLRZ vs BSLK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PLRZ Wins Head-to-Head Institutional Verdict (2–2 across 6 Pillars · 5–3 Matrix Metrics)

PLRZ Overall Winner 6-Pillar Tally: PLRZ 2 – 2 BSLK (2 Tie) Matrix Metrics: PLRZ 5 – 3 BSLK

As of Nov 16, 2026, Polyrizon Ltd. (PLRZ) is the stronger overall head-to-head candidate over Bolt Projects Holdings, Inc. (BSLK) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow). PLRZ carries a Unified Composite Score of 31.6/100 (SELL) at $10.70 (N/M Forward P/E, 0.0% operating margin), whereas BSLK carries 41.2/100 (SELL) at $0.58 (N/M Forward P/E, -1179.5% operating margin).

  • Composite vs. Pillar Nuance: While BSLK currently prints a higher short-term Unified Composite Score (41.2/100 SELL vs. PLRZ 31.6/100 SELL), PLRZ captures the overall institutional head-to-head verdict (5–3 matrix metrics and 2–2 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -1179.5% operating margin) and revenue trajectory (+0.0% vs. +7300.0% YoY).
  • Defensive Composite Rating Caution: Although PLRZ compares more favorably head-to-head, both PLRZ (31.6/100 SELL) and BSLK (41.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: PLRZ is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.4); meanwhile BSLK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 19.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PLRZ vs BSLK
PLRZ NASDAQ Head-to-Head Winner
Polyrizon Ltd. Ordinary Shares
Surgical & Medical Instruments & Apparatus
$10.70
-3.17% 1D
Market Cap $26.8M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -0.09β · 85% Vol
Unified Composite Score
31.6 / 100 SELL
Tech 17.0 Fund 33.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -4.9%) with fading momentum, RSI 49
RSI-14: 49.4 · SMA20: $10.20 · SMA50: $10.28
BSLK NASDAQ
Bolt Projects Holdings, Inc. Common Stock
Industrial Organic Chemicals
$0.58
-27.01% 1D
Market Cap $7.1M
TTM Revenue $3.1M
Forward P/E N/M
Beta / 30D Vol 4.04β · 148% Vol
Unified Composite Score
41.2 / 100 SELL
Tech 40.0 Fund 43.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.4%), weak momentum, RSI 20
RSI-14: 19.8 · SMA20: $1.63 · SMA50: $1.95

6-Pillar Scorecard Institutional Category Breakdown (PLRZ 2 – 2 BSLK)

Columns: Metric · PLRZ · BSLK
1. Valuation Multiples BSLK
Forward P/E N/M N/M
Trailing P/E N/M 0.1x
PEG Ratio N/M N/M
EV / Revenue N/M 4.9x
2. Growth & Scale BSLK
Revenue Growth (YoY) +0.0% +7300.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A $3.1M
Market Cap $26.8M $7.1M
3. Profitability & Quality PLRZ
Gross Margin N/A 3.2%
Operating Margin 0.0% -1179.5%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -21.4% -4288.3%
4. Balance Sheet & Cash Flow PLRZ
Cash Generation (TTM) N/A -$5.4M
Cash Flow Margin N/A N/A
Net Cash / Leverage $11.48 Book/Sh · -21.4% ROE $8.2M Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PLRZ (5) vs BSLK (3)
Institutional Metric PLRZ BSLK Criterion Row Edge
Market Capitalization
Scale
$26.8M $7.1M Larger Scale PLRZ
Trailing P/E Ratio
Valuation
N/M 0.1x Lower Multiple BSLK
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% +7300.0% Higher Growth BSLK
Operating Margin (TTM)
Profitability
0.0% -1179.5% Higher Margin PLRZ
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-21.4% -4288.3% Higher ROE PLRZ
52-Week Range Position
Momentum
58% ($0–$18) 0% ($1–$25) Stronger Trend PLRZ
Beta / 30D Volatility
Risk Regime
-0.09β · 85% Vol 4.04β · 148% Vol Lower Realized Risk PLRZ
Unified Institutional Score
Composite Signal
31.6 / 100 (SELL) 41.2 / 100 (SELL) Higher Composite BSLK
Trailing 12M Revenue (USD)
Operating Scale
N/A $3.1M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 3.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 4.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($11.48 Book/Sh · -21.4% ROE) -$5.4M ($8.2M Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PLRZ +147.79 pp
PLRZ: +73.94% · BSLK: -73.85%
3M Horizon PLRZ +1625.31 pp
PLRZ: +1555.84% · BSLK: -69.47%
6M Horizon PLRZ +1625.31 pp
PLRZ: +1555.84% · BSLK: -69.47%
1Y Horizon PLRZ +1625.31 pp
PLRZ: +1555.84% · BSLK: -69.47%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PLRZ vs BSLK. Trailing 12-month operating profitability (PLRZ 0.0% vs BSLK -1179.5%) and valuation multiples (PLRZ N/M vs BSLK N/M Forward P/E) are benchmarked directly in Pillar 4 below.

PLRZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-21.4% · N/M
BSLK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.1M
Gross Margin3.2%
Op. Margin-1179.5%
ROE / Fwd P/E-4288.3% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PLRZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PLRZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BSLK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BSLK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PLRZ Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $26.8M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
BSLK Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $7.1M market capitalization and -1179.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ PLRZ vs BSLK Key Questions & Quantitative Answers

As of Nov 16, 2026, Polyrizon Ltd. (PLRZ) is the stronger overall head-to-head candidate over Bolt Projects Holdings, Inc. (BSLK) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow). PLRZ carries a Unified Composite Score of 31.6/100 (SELL) at $10.70 (N/M Forward P/E, 0.0% operating margin), whereas BSLK carries 41.2/100 (SELL) at $0.58 (N/M Forward P/E, -1179.5% operating margin). Composite vs. Pillar Nuance: While BSLK currently prints a higher short-term Unified Composite Score (41.2/100 SELL vs. PLRZ 31.6/100 SELL), PLRZ captures the overall institutional head-to-head verdict (5–3 matrix metrics and 2–2 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -1179.5% operating margin) and revenue trajectory (+0.0% vs. +7300.0% YoY). Defensive Composite Rating Caution: Although PLRZ compares more favorably head-to-head, both PLRZ (31.6/100 SELL) and BSLK (41.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: PLRZ is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.4); meanwhile BSLK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 19.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BSLK leads the Growth & Scale pillar: PLRZ posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with BSLK at +7300.0% YoY revenue growth and +0.0% YoY earnings growth on $3.1M TTM revenue (3.2% gross margin, -1179.5% operating margin). On trailing 12-month operating scale, PLRZ generates N/A in USD-normalized revenue versus $3.1M for BSLK. In operating R&D and SG&A reinvestment, PLRZ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BSLK.

BSLK screens cheaper on headline valuation multiples. PLRZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BSLK trades at N/M Forward P/E, 0.1x Trailing P/E, N/M PEG, and 4.9x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PLRZ (-21.4% ROE) versus BSLK (-4288.3% ROE) capital efficiency.

In options market volatility and institutional positioning, PLRZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.09β · 85% Vol realized risk). By comparison, BSLK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.04β · 148% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.